[EN] THERMALLY STABLE VOLATILE FILM PRECURSORS<br/>[FR] PRÉCURSEURS DE FILM MINCE VOLATILS ET THERMIQUEMENT STABLES
申请人:UNIV WAYNE STATE
公开号:WO2010132871A1
公开(公告)日:2010-11-18
A precursor for the deposition of a thin film by atomic layer deposition is provided. The compound has the formula MxLy where M is a metal and L is an amidrazone-derived ligand or an amidate-derived ligand. A process of forming a thin film using the precursors is also provided.
The present invention discloses a novel thyroid like compounds of formula (I), wherein R
1
R
2
, R
3
, R
4
and Z are as defined in the specification, method for its preparation, composition containing such compounds and use of such compounds and composition as medicament. Further, compounds of formula (I) has significantly low binding affinity to thyroid receptors and thus considerably devoid of thyrotoxic effects. The invention also relates to the use of the compound of formula (I) for the preparation of a medicament for treating various disease conditions such as obesity, dyslipidemia, metabolic syndrome and co-morbidities associated with metabolic syndrome.
Disclosed are polymers comprising the moiety A, which is a moiety of formula I: and pharmaceutically acceptable salts thereof, wherein R, R
1
, R
2
, L, n1 and n2 are as defined herein. These polymers are useful for delivering nucleic acids to subject. These polymers and pharmaceutically acceptable compositions comprising such polymers and nucleic acids can be useful for treating various diseases, disorders and conditions.
The present invention provides triazole compounds useful as inhibitors of Acetyl CoA Carboxylase (ACC), compositions thereof, and methods of using the same.
本发明提供了三唑化合物,可用作乙酰辅酶A羧化酶(ACC)的抑制剂,以及其组合物和使用方法。
[EN] SUBSTITUTED PIPERIDINES AS RENIN INHIBITORS<br/>[FR] PIPÉRIDINES SUBSTITUÉES EN TANT QU'INHIBITEURS DE LA RÉNINE
申请人:NOVARTIS AG
公开号:WO2009098275A1
公开(公告)日:2009-08-13
The present invention relates to compounds of the general formula (I) and the salts thereof, preferably the pharmaceutically acceptable salts thereof; in which R has the meaning explained in the description, a process for their preparation and the use of these compounds as medicines, especially as renin inhibitors.